153 related articles for article (PubMed ID: 24167380)
21. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G
Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of serum miR-25 in non-small-cell lung cancer.
Li J; Yu M; Liu Z; Liu B
Br J Biomed Sci; 2019 Jul; 76(3):111-116. PubMed ID: 30919763
[No Abstract] [Full Text] [Related]
23. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients.
Zhang J; Wang T; Zhang Y; Wang H; Wu Y; Liu K; Pei C
Cancer Biomark; 2018; 21(4):763-768. PubMed ID: 29286916
[TBL] [Abstract][Full Text] [Related]
24. IDH2 is a novel diagnostic and prognostic serum biomarker for non-small-cell lung cancer.
Li JJ; Li R; Wang W; Zhang B; Song X; Zhang C; Gao Y; Liao Q; He Y; You S; Tan Z; Luo X; Li Y; Tang M; Weng X; Yi W; Peng S; Liu S; Tan Y; Bode AM; Cao Y
Mol Oncol; 2018 May; 12(5):602-610. PubMed ID: 29465809
[TBL] [Abstract][Full Text] [Related]
25. High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer.
Ilie M; Mazure NM; Hofman V; Ammadi RE; Ortholan C; Bonnetaud C; Havet K; Venissac N; Mograbi B; Mouroux J; Pouysségur J; Hofman P
Br J Cancer; 2010 May; 102(11):1627-35. PubMed ID: 20461082
[TBL] [Abstract][Full Text] [Related]
26. Time courses and value of circulating microparticles in patients with operable stage non-small cell lung cancer undergoing surgical intervention.
Tseng CC; Wang CC; Hsiao CC; Lu HI; Leu S; Chang HC; Huang KT; Fang WF; Chen YM; Liu SF; Yang CT; Lin MC; Yip HK
Tumour Biol; 2016 Sep; 37(9):11873-11882. PubMed ID: 27059732
[TBL] [Abstract][Full Text] [Related]
27. Rethinking Autoantibody Signature Panels for Cancer Diagnosis.
Campa MJ; Gottlin EB; Herndon JE; Patz EF
J Thorac Oncol; 2017 Jun; 12(6):1011-1014. PubMed ID: 28126538
[TBL] [Abstract][Full Text] [Related]
28. Serum pleiotrophin could be an early indicator for diagnosis and prognosis of non-small cell lung cancer.
Du ZY; Shi MH; Ji CH; Yu Y
Asian Pac J Cancer Prev; 2015; 16(4):1421-5. PubMed ID: 25743809
[TBL] [Abstract][Full Text] [Related]
29. Serum macrophage inhibitory cytokine-1 as a clinical marker for non-small cell lung cancer.
Xu C; Li L; Wang W; Zhang Q; Zhang X; Yang R
J Cell Mol Med; 2021 Mar; 25(6):3169-3172. PubMed ID: 33605059
[TBL] [Abstract][Full Text] [Related]
30. Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer.
Tanaka S; Hattori N; Ishikawa N; Shoda H; Takano A; Nishino R; Okada M; Arihiro K; Inai K; Hamada H; Yokoyama A; Kohno N
Int J Cancer; 2012 Jan; 130(2):377-87. PubMed ID: 21351094
[TBL] [Abstract][Full Text] [Related]
31. Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer.
Shoji F; Morodomi Y; Akamine T; Takamori S; Katsura M; Takada K; Suzuki Y; Fujishita T; Okamoto T; Maehara Y
Lung Cancer; 2016 Aug; 98():15-21. PubMed ID: 27393501
[TBL] [Abstract][Full Text] [Related]
32. Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.
Noreldeen HAA; Du L; Li W; Liu X; Wang Y; Xu G
J Pharm Biomed Anal; 2020 Jun; 185():113220. PubMed ID: 32145537
[TBL] [Abstract][Full Text] [Related]
33. Serum microRNA-135a downregulation as a prognostic marker of non-small cell lung cancer.
Zhang YK; Sun B; Sui G
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27525941
[TBL] [Abstract][Full Text] [Related]
34. [Pre-operative plasma D-dimer level may predict the poor prognosis within one year after the surgery for non-small cell lung cancer].
Wang Z; Fu J; Diao D; Dang C
Zhongguo Fei Ai Za Zhi; 2011 Jun; 14(6):534-7. PubMed ID: 21645459
[TBL] [Abstract][Full Text] [Related]
35. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
Shi GL; Chen Y; Sun Y; Yin YJ; Song CX
Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic and prognostic value of serum periostin in patients with non-small cell lung cancer.
Xu CH; Wang W; Lin Y; Qian LH; Zhang XW; Wang QB; Yu LK
Oncotarget; 2017 Mar; 8(12):18746-18753. PubMed ID: 27816968
[TBL] [Abstract][Full Text] [Related]
37. Early detection of NSCLC with scFv selected against IgM autoantibody.
Pedchenko T; Mernaugh R; Parekh D; Li M; Massion PP
PLoS One; 2013; 8(4):e60934. PubMed ID: 23585862
[TBL] [Abstract][Full Text] [Related]
38. Low serum miR-98 as an unfavorable prognostic biomarker in patients with non-small cell lung cancer.
Wang K; Dong L; Fang Q; Xia H; Hou X
Cancer Biomark; 2017 Sep; 20(3):283-288. PubMed ID: 28946561
[TBL] [Abstract][Full Text] [Related]
39. Serum level of microRNA-147 as diagnostic biomarker in human non-small cell lung cancer.
Chu G; Zhang J; Chen X
J Drug Target; 2016 Aug; 24(7):613-7. PubMed ID: 26581116
[TBL] [Abstract][Full Text] [Related]
40. Comparison of cofilin‑1 and Twist‑1 protein expression in human non‑small cell lung cancer tissues.
Chang CY; Chang SL; Leu JD; Chang YC; Hsiao M; Lin LT; Lin HN; Lee YJ
Oncol Rep; 2019 Aug; 42(2):805-816. PubMed ID: 31233187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
